Robert E. Waltermire

Insider Reports History

Entity
Individual
Location
Four Tower Bridge, 200 Barr Harbor Drive, Suite 200, West Conshohocken, PA
Signature
/s/ Mardi Dier, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert E. Waltermire:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MADRIGAL PHARMACEUTICALS, INC. Senior VP, Chief Pharma Dev. Common Stock 5.5K $1.54M $280.00 Jun 14, 2024 Direct
MADRIGAL PHARMACEUTICALS, INC. Senior VP, Chief Pharma Dev. Market Stock Unit 1.42K $346K $243.92 Jan 23, 2024 Direct
MADRIGAL PHARMACEUTICALS, INC. Senior VP, Chief Pharma Dev. Stock Option (Right to Buy) 10.4K Jun 14, 2024 Direct

Insider Reports Filed by Robert E. Waltermire

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MDGL MADRIGAL PHARMACEUTICALS, INC. Jun 14, 2024 3 -$367K 4 Jun 18, 2024 Senior VP, Chief Pharma Dev.
MDGL MADRIGAL PHARMACEUTICALS, INC. Jun 12, 2024 3 -$394K 4 Jun 14, 2024 Senior VP, Chief Pharma Dev.
MDGL MADRIGAL PHARMACEUTICALS, INC. May 21, 2024 1 -$240K 4 May 23, 2024 Senior VP, Chief Pharma Dev.
MDGL MADRIGAL PHARMACEUTICALS, INC. Jan 23, 2024 3 $0 4 Jan 25, 2024 Senior VP, Chief Pharma Dev.
MDGL MADRIGAL PHARMACEUTICALS, INC. Jan 16, 2024 1 -$134K 4 Jan 18, 2024 Senior VP, Chief Pharma Dev.
MDGL MADRIGAL PHARMACEUTICALS, INC. Dec 14, 2023 8 -$590K 4 Dec 18, 2023 Senior VP, Chief Pharma Dev.
MDGL MADRIGAL PHARMACEUTICALS, INC. Dec 12, 2023 8 -$513K 4 Dec 14, 2023 Senior VP, Chief Pharma Dev.
MDGL MADRIGAL PHARMACEUTICALS, INC. Feb 28, 2023 10 -$1.85M 4 Mar 2, 2023 Senior VP, Chief Pharma Dev.
MDGL MADRIGAL PHARMACEUTICALS, INC. Jan 16, 2023 1 $0 4 Jan 18, 2023 Senior VP, Chief Pharma Dev.
MDGL MADRIGAL PHARMACEUTICALS, INC. Feb 24, 2022 1 $0 4 Feb 24, 2022 Senior VP, Chief Pharma Dev.
MDGL MADRIGAL PHARMACEUTICALS, INC. Aug 2, 2021 1 $0 4 Aug 4, 2021 Senior VP, Chief Pharma Dev.
MDGL MADRIGAL PHARMACEUTICALS, INC. Aug 2, 2021 0 $0 3 Aug 4, 2021 Senior VP, Chief Pharma Dev.